scholarly article | Q13442814 |
P50 | author | Baek Gyu Jun | Q59692250 |
P2093 | author name string | Moon Young Kim | |
Soon Koo Baik | |||
Sang Ok Kwon | |||
Yoon Ok Jang | |||
P2860 | cites work | Molecular cloning and expression of human hepatocyte growth factor | Q24305558 |
History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells | Q28190388 | ||
Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy | Q28246439 | ||
Liver fibrosis | Q29547449 | ||
Liver regeneration | Q29614743 | ||
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease | Q33240935 | ||
Transplantation of bone marrow cells reduces CCl4 -induced liver fibrosis in mice. | Q33751766 | ||
Hepatic stellate cells as a target for the treatment of liver fibrosis | Q34391409 | ||
Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. | Q34539733 | ||
Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. | Q35083777 | ||
Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model | Q35450695 | ||
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells | Q36174278 | ||
Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases | Q37729256 | ||
Regulation of hemopoiesis by bone marrow stromal cells and their products | Q37925511 | ||
Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice | Q40393876 | ||
Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation | Q40581730 | ||
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies | Q40911465 | ||
Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis | Q42239154 | ||
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. | Q42947269 | ||
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes | Q45054700 | ||
Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. | Q46004819 | ||
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis | Q46476283 | ||
Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. | Q50894482 | ||
Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. | Q53508406 | ||
IL-6 induces hepatic inflammation and collagen synthesis in vivo. | Q54638501 | ||
Isolation and identification of mesenchymal stem cells from human fetal pancreas. | Q54771966 | ||
Characterization and Clinical Application of Human CD34+Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor | Q61054157 | ||
Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha | Q70998052 | ||
Proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63) cultured on previously used titanium surfaces | Q72995567 | ||
Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair | Q73285228 | ||
Transforming growth factor-beta signaling and cirrhosis | Q77808068 | ||
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B | Q82822290 | ||
Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis | Q83803280 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | mesenchymal stem cell | Q1922379 |
P304 | page(s) | 141-149 | |
P577 | publication date | 2015-06-26 | |
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis | |
P478 | volume | 21 |
Q36679690 | 3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose-Derived MSCs and Improves Their Therapeutic Effects on Hepatic Fibrosis |
Q41191069 | Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress |
Q93379581 | Cytokinome of adult-derived human liver stem/progenitor cells: immunological and inflammatory features |
Q38931032 | Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis |
Q40629414 | Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis |
Q39000508 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis. |
Q46307085 | Mammalian MSC from selected species: Features and applications |
Q88484640 | Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study |
Q90225107 | Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope? |
Q36059842 | MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells |
Q57492704 | Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells |
Q37214779 | Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells |
Q39429850 | Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon |
Q36273664 | Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis |
Q92855314 | Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis |
Q93041069 | The Effect of Mesenchymal Stem Cells Derived Microvesicles on the Treatment of Experimental CCL4 Induced Liver Fibrosis in Rats |
Q41846141 | Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension? |
Q36298209 | Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis |
Q50236829 | Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial |
Search more.